Celltrion announced on the 17th that it has signed a contract manufacturing agreement for pharmaceuticals worth 294.9 billion won with a global pharmaceutical company.



This amount is equivalent to 8.29% of the company's recent sales. The contract period runs from March 16, 2026, to December 31, 2029.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing